What is Bharat Biotech's plan for vaccine of children?
- 3 years ago
Amid alert of the third wave of coronavirus, it is being said that children are at high risk. But now there is good news for the parents. Vaccine trials on children are about to begin in India. If it gets successful then children will also be able to be protected to a greater extent from corona infection. The trial of Covaxin will be done on children aged 2 to 18 years. What is Bharat Biotech's plan for vaccine of children, ICMR scientists explains in this report.